Journal article
Dialysis patients treated with Epoetin α show improved exercise tolerance and physical function: A new analysis of the Canadian Erythropoietin Study Group trial
Abstract
The risks/benefits of anemia treatment in dialysis patients have been redefined in the US Epoetin α label. This analysis was carried out to determine if increasing hemoglobin (Hb) levels improve exercise tolerance and physical function in anemic dialysis patients. This is a new analysis of the Canadian Erythropoietin Study Group trial, a double-blind, randomized, placebo-controlled trial in dialysis patients. Subjects were 18 to 75 years old, …
Authors
Muirhead N; Keown PA; Churchill DN; Poulin-Costello M; Gantotti S; Lei L; Gitlin M; Mayne TJ
Journal
Hemodialysis International, Vol. 15, No. 1, pp. 87–94
Publisher
Wiley
Publication Date
1 2011
DOI
10.1111/j.1542-4758.2010.00508.x
ISSN
1492-7535